Lifecore Biomedical, Inc. ( LFCR) - Stock Earnings
LFCR Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 5, 2026, midnight | — / — | — | — / — | — |
LFCR Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -35.6 million USD | 25.5 million USD |
| 2024Q4 | -14.8 million USD | 35.2 million USD |
| 2025Q4 | -15.0 million USD | 23.2 million USD |
LFCR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -116.7 million USD | 111.3 million USD |
| 2024 | 12.0 million USD | 128.3 million USD |
| 2025 | -38.7 million USD | 128.9 million USD |
| 2026 Est. | — | — |
LFCR
Price: $4.59
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.27 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 189.4 million